Carbamazepine: a 'blind' assessment of CYP-associated metabolism and interactions in human liver-derived in vitro systems

References

• AITIO, A., 1978, A simple and sensitive assay of 7-hydroxycoumarin deethylation. Annals of Biochemistry, 85, 488–491.
   Web of Science ®Google Scholar
• ANDERSSON, T. B., SJOBERG, H., HOFFMAN, K.-J., BOOBIS, A. R., WATTS, P., EDWARDS, R. J., LAKE, B. G., PRICE, R. J., RENWIC, A. B., GrOmEz-LE0i6N, M. J., CASTELL, J. V., INGELMAN-SUNDBERG, M., HIDESTRAND, M., GOLDFARB, P., LEWIS, D., CORCOS, L., GUILLOUZO, A., TAAVITSAINEN, P. and PELKONEN, O., 2001, An assessment of human liver-derived in vitro systems to predict the in vivo metabolism and clearance of Almokalant, Drug Metabolism and Disposition, 29, 712–720.
   Google Scholar
• BEAMAND, J. A., PRICE, R. J., CUNNIGHAM, M. E. and LAKE, B. G., 1993, Culture of precision-cut liver slices: effect of some peroxisome proliferators. Food and Chemical Toxicology, 31, 137–147.
   PubMed Web of Science ®Google Scholar
• BERTILSSON, L., TYBRING, G., WIDEN, J., CHANG, M. and TOMSON, T., 1997, Carbamazepine treatment induces the CYP3A4 catalysed sulphoxidation of omepratzole, but has no or less effect on hydroxylation via CYP2C19. British Journal of Clinical Pharmacology, 44, 186–189.
   PubMed Web of Science ®Google Scholar
• BEYER, C. and SPITELLER, G., 1992, A new carbamazepine metabolite in uraemic filtrate. Xenobiotica, 22, 1029–1035.
   PubMed Web of Science ®Google Scholar
• BORENFREUND, H., BABIC H. and MARTIN-ALGUACIL, N., 1988, Comparisons of two in vitro cytotoxicity assays — the neutral red (NR) and tetrazolium MTT tests. Toxicology In Vitro, 2, 1–6.
   Google Scholar
• BRADFORD, M. M., 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Annals of Biochemistry, 72, 248–254.
   Web of Science ®Google Scholar
• BURKE, M. D., PROUGH, R. A. and MAYER, R. T., 1977, Characteristics of a microsomal cytochrome P- 448-mediated reaction ethoxyresorufin O-deethylation. Drug Metabolism and Disposition, 5, 1–8.
   PubMed Web of Science ®Google Scholar
• DOLLERY, C., 1991, Carbamazepine. In C. Dollery (ed.), Therapeutic Drugs (Edinburgh: Churchill Livingstone), pp. C49–53.
   Google Scholar
• DONATO, M. T., CASTELL, J. V. and GômEz-LEmON, M. J., 1995, Effect of model inducers on cytochrome P450 activities of human hepatocytes in primary cultures. Drug Metabolism and Disposition, 23, 553–558.
   Google Scholar
• EDWARDS, R. J., ADAMS, D. A., WATTS, P. S., DAVIES, D. S. and BOOBIS, A. R., 1998, Development of a comprehensive panel of antibodies against the major xenobiotic metabolising forms of cytochrome P450 in humans. Biochemical Pharmacology, 56, 377–387.
   PubMed Web of Science ®Google Scholar
• FAIGLE, J. W. and FELDMAN, K. F., 1995, Carbamazepine. Chemistry and biotransformation. In R. H. Levy, R. H. Mattson and B. S. Meldrum (eds), Ant iepileptic Drugs, 4th edn (New York: Raven), pp. 499–513.
   Google Scholar
• GómEz-LEctioN, M. J., DONATO, M. T., PONSODA, X., FABRA, R., TRULLENQUE, R. and CASTELL, J. V., 1997, Isolation, culture and use of human hepatocytes in drug research. In J. V. Casten and M. J. Górnez-Lechtien (eds), In Vitro Methods in Pharmaceutical Research (London: Academic Press), pp. 129–154.
   Google Scholar
• GUGUEN-GUILLOUZO, C., CAMPION, J. P., BRISSOT, P., GLAISE, D., LAUNOIS, B., BOUREL, M. and GuILLouzo, A., 1 982, High yield preparation of isolated human adult hepatocytes by enzymatic perfusion of the liver. Cell Biology and International Reports, 6, 625–628.
   Google Scholar
• HOUSTON, J. B. and CARLILE, D. J., 1997, Prediction of hepatic clearance from microsomes, hepatocytes, and liver slices. Drug Metabolism Reviews, 129, 891–922.
   Web of Science ®Google Scholar
• INGELMAN-SUNDBERG, M. and JOHANSSON, I., 1980, Cytochrome b5 as electron donor to rabbit liver cytochrome P-450 in reconstituted phospholipid vesicles. Biochemistry and Biophysical Research Communications, 97, 582–589.
   PubMed Web of Science ®Google Scholar
• ITO, K., IWATSUBO, T., KANAMITSU, 5, NAKAJIMA, Y. and SUGIYAMA, Y., 1998, Quantitative prediction of in vivo drug clearance and drug interactions from in vitro data on metabolism, together with binding and transport. Annual Reviews in Pharmacology and Toxicology, 38, 461–499.
   Google Scholar
• KENNEDY, T., 1997, Managing the drug discovery/development interface. Drug Discovery Today, 2, 436–444.
   Web of Science ®Google Scholar
• KERR, B. M. and LEVY, R. H., 1995, Carbamazepine. Carbamazepine epoxide. In R. H. Levy, R. H. Mattson and B. S Meldrum (eds), Antiepileptic Drugs, 4th edn (New York: Raven), pp. 529–541.
   Google Scholar
• KERR, B. M., THUMMEL, K. E., WURDEN, C. J., KLEIN, S. M., KROETZ, D. L., GONZALEZ, F. J. and LEVY, R. H., 1994, Human liver carbamazepine metabolism. Role of CYP3A4 and CYP2C8 in 10,11-epoxide formation. Biochemical Pharmacology, 47, 1969–1070.
   PubMed Web of Science ®Google Scholar
• KNODELL, R. G., HALL, S. D., WILKINSON, G. R. and GUENGERICH, F. P., 1987, Hepatic metabolism of tolbutamide: Characterization of the form of cytochrome P-450 involved in methyl hydroxylation and relationship to in vivo disposition. Journal of Pharmacology and Experimental Therapeutics, 241, 1112–1119.
   PubMed Web of Science ®Google Scholar
• KRONBACH, T., MATHYS, D., GUT, J., CATIN, T. and MEYER, U. A., 1987, High-performance liquid chromatographic assays for bufuralol l'-hydroxylase, debrisoquine 4-hydroxylase, and dextromethorphan O-demethylase in microsomes and purified cytochrome P-450 isozymes of human liver. Annals of Biochemistry, 162, 24–32.
   Web of Science ®Google Scholar
• KRUMDIECK, C. L., DOS SANTOS, J. E. and Ho, K. J., 1980, A new instrument for the rapid preparation of tissue slices. Annals of Biochemistry, 104, 118–123.
   Web of Science ®Google Scholar
• KRYNETSKI, E. Y., DRUTSA, V. L., KOVALEVA, I. E. and Luzocov, V. N., 1995, High yield expression of functionally active human liver CYP2D6 in yeast cells. Pharmacogenetics, 5, 103–109.
   PubMedGoogle Scholar
• LAKE, B. G., BALL, S. E., RENWICK, A. B., TREDGER, J. M., KAO, J., BEAMAND, J. A. and PRICE, R. J., 1997, Induction of CYP 3A isoforms in cultured precision-cut human liver slices. Xenobiotica, 27, 1165–1173.
   PubMed Web of Science ®Google Scholar
• LAKE, B. G., TREDGER, J. M., RENWICK, A. B., BARTON, P. B. and PRICE, R. J., 1998, 3,3'-Diindoloylmethane induces CYP1A2 in cultured precision-cut human liver slices. Xenobiotica, 28, 803–811.
   PubMed Web of Science ®Google Scholar
• LERTRATANANGKOON, K. and HORNING, M. G., 1982, Metabolism of carbamazepine. Drug Metabolism and Disposition, 10, 1–10.
   PubMed Web of Science ®Google Scholar
• LEVY, R. H. and WURDEN, C. J., 1995, Carbamazepine. Interactions with other drugs. In R. H. Levy, R. H. Mattson and B. S. Meldrum (eds), Antiepileptic Drugs, 4th edn (New York: Raven), pp. 543–554.
   Google Scholar
• LEWIS, D. F. V., 1996, Cytochromes P450: Structure, Function and Mechanism (London: Taylor & Francis).
   Google Scholar
• LEWIS, D. F. V., DICKINS, M., EDDERSHAW, P. J., TARBIT, M. H. and GOLDFARB, P. G., 1999, Cytochrome P450 substrate specificities, substrate structural templates and enzyme active site geometries. Drug Metabolism and Drug Interactions, 15, 1–49.
   Google Scholar
• Li, H. and PouLos, T. L., 1997, The structure of the cytochrome p450BM-3 haem domain complexed with the fatty acid substrate, palmitoleic acid. Nature Structural Biology, 4, 140–146.
   PubMedGoogle Scholar
• LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L. and RANDALL, R. J., 1951, Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
   PubMed Web of Science ®Google Scholar
• MORSELLI, P. L., 1995, Carbamazepine. Absorption, distribution and excretion. In R. H. Levy, R. H. Mattson and B. S. Meldrum (eds), Antiepileptic Drugs, 4th edn (New York: Raven), pp. 515–528.
   Google Scholar
• OSCARSON, M., HIDESTRAND, M., JOHANSSON, I. and INGELMAN-SUNDBERG, M., 1997, A combination of mutations in the CYP2D6*17 (CYP2D6Z) allele causes alterations in enzyme function. Molecular Pharmacology, 52, 1034–1040.
   Google Scholar
• PARK, Y. H., KULLBERG, M. P. and HINSVARK, O. N., 1984, Quantitative determination of dextromethorphan and three metabolites in urine by reverse-phase high-performance liquid chromatography. Journal of Pharmacological Science, 73, 24–29.
   PubMed Web of Science ®Google Scholar
• PELKONEN, O., MAENPAA, J., TAAVITSAINEN, P., RAUTIO, A. and RAUNIO, H., 1998, Inhibition and induction of human cytochrome P450 (CYP) enzymes. Xenobiotica, 28, 1203–1253.
   PubMed Web of Science ®Google Scholar
• PETER, R., BOCKER, R., BEAUNE, P. H., IWASAKI, M., GUENGERICH, F. P. and YANG, C. S., 1990, Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-45011E1. Chemical Research in Toxicology, 3, 566–573.
   PubMed Web of Science ®Google Scholar
• PIENIMAKI, P., FucHs, S., IsojARATI, J. and VAHAKANGAs, K., 1995, Improved detection and quantitation of carbamazepine and oxcarbazepine and their metabolites by high-performance liquid chromatography. Journal of Chromatography B, 673, 97–105.
   PubMed Web of Science ®Google Scholar
• PRENTIS, R. A., Lis, Y. and WALKER, S. R., 1988, Pharmaceutical innovation by the seven UK-owned pharmaceutical companies 1964-1985. British Journal of Clinical Pharmacology, 25, 387–396.
   PubMed Web of Science ®Google Scholar
• RAUNIO, H., SYNGELMA, T., PASANEN, M., JUVONEN, R., HONKAKOSKI, P., KAIRALUOMA, M. A., SOTANIEMI, E., LANG, M. A. and PELKONEN, O., 1988, Imrnunochemical and catalytical studies on hepatic coumarin 7-hydroxylase in man, rat and mouse. Biochemical Pharmacology, 37, 3889–3895.
   PubMed Web of Science ®Google Scholar
• RAUNIO, H., VALTONEN, J., HONKAKOSKI, P., LANG, M. A., STAHLBERG, M., KAIRALUOMA, M. A., RAUTIO, A., PASANEN, M. and PELKONEN, O., 1990, Imrnunochemical detection of human liver cytochrome P450 forms related to phenobarbital-inducible forms in the mouse. Biochemical Pharmacology, 40, 2503–2509.
   PubMed Web of Science ®Google Scholar
• RAVICHANDRAN, K. G., BODDUPALLI, S. S., HASERMANN, C. A., PETERSON, J. A. and DEISENHOFER, J., 1993, Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450's. Science, 261, 731–736.
   PubMed Web of Science ®Google Scholar
• RODRIGUES, A. D., 1994, Use of in vitro human metabolism studies in drug development. An industrial perspective. Biochemical Pharmacology, 48, 2147–2156.
   PubMed Web of Science ®Google Scholar
• RODRIGUES, A. D., 1999, Integrated cytochrome P450 reaction phenotyping. Attempting to bridge the gap between cDNA-expressed cytochromes p450 and native human liver microsomes. Biochemical Pharmacology, 57, 465–480.
   PubMed Web of Science ®Google Scholar
• SHEN, A. L., PORTER, T. D., WILSON, T. E. and KASPER, C. B., 1989 Structural analysis of the FMN binding domain of NADPH-cytochrome P-450 oxidoreductase by site-directed mutagenesis. Journal of Biological Chemistry, 264, 7584–7589.
   PubMed Web of Science ®Google Scholar
• SULLIVANKLOSE, T. H., GHANAYEM, B. I., BELL, D. A., ZHANG, Z.Y., KAMINSKY, L. S., SHENFIELD, G. M., MINERS, J. O., BIRKETT, D. J. and GOLDSTEIN, J. S., 1996, The role of the CYP2C9-Leu359 allelic variant in the tolbutamide polymorphism. Pharmacogenetics, 6, 341–349.
   PubMedGoogle Scholar
• TOMSON, T., TYBRING, G. and BERTILSSON, L., 1983, Single-dose kinetics and metabolism of carbamazepine-10,11-epoxide. Clinical Pharmacology and Therapy, 33, 58–65.
   PubMed Web of Science ®Google Scholar
• TRUAN, G., CULLIN, C., REISDORF, P., URBAN, P. and POMPON, D., 1993, Enhanced in vivo monooxygenase activities of mammalian P450s in engineered yeast cells producing high levels of NADPH-P450 reductase and human cytochrome bs. Gene, 125, 49–55.
   PubMed Web of Science ®Google Scholar
• WAXMAN, D. J., LAPENSON, D. P., AOYAMA, T., GELBOIN, H. V., GONZALES, F. J. and KORZEKWA, K., 1991, Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450s. Archives in Biochemistry and Biophysics, 290, 160–166.
   PubMed Web of Science ®Google Scholar
• WORBOYS, P. D., BRADBURY, A. and HOUSTON, J. B., 1995, Kinetics of drug metabolism in rat liver slices. Rates of oxidation of ethoxycoumarin and tolbutamide, examples of high- and low-clearance compounds. Drug Metabolism and Disposition, 23, 393–397.
   PubMed Web of Science ®Google Scholar
• WRIGHTON, S. A., STEVENS, J. C., BECKER, G. W. and VANDENBRANDEN, M., 1993, Isolation and characterization of human liver cytochrome P450 2C19: correlation between 2C19 and S-mephenytoin 4'-hydroxylation. Archives of Biochemistry and Biophysics, 306, 240–245.
   PubMed Web of Science ®Google Scholar